{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T20:53:11Z","timestamp":1725483191772},"reference-count":55,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,30]],"date-time":"2006-01-30T00:00:00Z","timestamp":1138579200000},"content-version":"vor","delay-in-days":2130,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Vascular cognitive impairment is considered the second most common form of mental deterioration in the elderly after degenerative dementias. Therapeutic approaches to vascular dementia mainly rely on the identification and treatment of risk factors. A number of drugs have also been tested with the aim of improving or slowing cognitive decline in patients affected by various forms of cerebrovascular disease. Most of these trials have yielded unsatisfactory results. We hypothesize that some of these failures depend on the inclusion of patients with pathophysiologically heterogeneous types of vascular cognitive decline. In this paper, we review some of the most important trials that tested drugs with a preventive or therapeutic aim in vascular dementia patients. Preliminary results suggest that some beneficial effects can be detected only when the trial population is homogeneous on a clinical and pathogenic basis. In particular, subcortical vascular dementia, a form with a rather univocal clinical, radiological, and pathological picture, seems a particularly apt choice as a target for future clinical studies. At present, only one therapeutic trial is being conducted in patients affected by this specific form of vascular dementia.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2000.tb06407.x","type":"journal-article","created":{"date-parts":[[2006,1,30]],"date-time":"2006-01-30T14:39:26Z","timestamp":1138631966000},"page":"510-521","source":"Crossref","is-referenced-by-count":23,"title":["Subcortical Vascular Dementia as a Specific Target for Clinical Trials"],"prefix":"10.1111","volume":"903","author":[{"given":"DOMENICO","family":"INZITARI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TIMO","family":"ERKINJUNTTI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDERS","family":"WALLIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TEODORO","family":"DEL SER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MARCO","family":"ROMANELLI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LEONARDO","family":"PANTONI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,30]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.3.473"},{"key":"e_1_2_6_3_2","first-page":"250","article-title":"Vascular dementia: diagnostic criteria for research studies","volume":"43","author":"Rom\u00e1n G.C.","year":"1993","journal-title":"Report of the NINDS-AIREN International Work-shop. Neurology"},{"key":"e_1_2_6_4_2","unstructured":"World Health Organization. 1993. ICD\u201010 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO. Geneva. pp. 36\u201340."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1998.tb06015.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199100520-00006"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106719"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1987.tb05467.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199100520-00009"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.1987.03400130096040","article-title":"Senile dementia of the Binswanger type: a vascular form of dementia in the elderly","volume":"258","author":"Roman G.C.","year":"1987","journal-title":"JAMA"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.18.1.2"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.36.3.340"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.14.1.5"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92327-1"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.1986.03380160061021","article-title":"Improved cognition after control of risk factors for multi\u2010infarct dementia","volume":"256","author":"Meyer J.S.","year":"1986","journal-title":"JAMA"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03086-4"},{"key":"e_1_2_6_17_2","first-page":"3255","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension","volume":"265","author":"SHEP Cooperative Research Group","year":"1991","journal-title":"Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0047-6374(92)90083-P"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-4580(92)90012-M"},{"key":"e_1_2_6_20_2","first-page":"669","article-title":"Nimodipine","volume":"37","author":"Langley M.S.","year":"1989","journal-title":"A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in cerebrovascolar disease. Drugs"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540340047031"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100034351"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1989.tb05688.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.62.3.269"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.23.10.1434"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.23.9.1225"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1996.00550070088015"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.1.52"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.18.4.503"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410420606"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.2.543"},{"key":"e_1_2_6_32_2","first-page":"363","article-title":"Review of clinical studies with ergots in gerontology","volume":"23","author":"Venn R.D.","year":"1980","journal-title":"Adv. Bio-chem. Psychopharmacology"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1994.00540200063018"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106595"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(96)00127-X"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106650"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000051188"},{"issue":"2","key":"e_1_2_6_38_2","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/00002093-199803001-00005","article-title":"Propentofylline in the treatment of vascular dementia and Alzheimer\u2010type dementia: overview of phase I and phase II clinical trials","volume":"12","author":"Mielke R.","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1997.tb48481.x"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1996.tb34453.x"},{"issue":"4","key":"e_1_2_6_41_2","first-page":"S182","article-title":"Long\u2010term efficacy and safety of propentofylline in patients with vascular dementia: results of a 12 months placebo\u2010controlled trial [abstract]","volume":"19","author":"Pischel T.","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1159\/000117279"},{"key":"e_1_2_6_43_2","unstructured":"Kittner B. 1998. Presented at the Osaka Conference on Vascular Dementia October 7\u20139. Osaka Japan. Personal communication."},{"key":"e_1_2_6_44_2","unstructured":"Qizilbash N. J. Lopez Arrieta & J. Birks. 1997. Nimodipine in the treatment of primary degenerative mixed and vascular dementia.InDementia and Cognitive Module of the Cochrane Database of Systematic Reviews. [updated 03 June 1997]. H. Beppu F. Huppert J. Kayeet al. Eds. Available in The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration; Issue 3. Update Software; updated quarterly. Oxford. Oxfore U.K."},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199619060-00003"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1996.tb00026.x"},{"key":"e_1_2_6_47_2","first-page":"1327","article-title":"A placebo\u2010controlled, double\u2010blind, randomized trial of an extract of ginkgo biloba for dementia","volume":"278","author":"Le Bars P.L.","year":"1997","journal-title":"North American EGb Study Group. JAMA"},{"key":"e_1_2_6_48_2","doi-asserted-by":"crossref","unstructured":"Pearsons C.G. W. Danysz & G. Quack. 1999. Memantine is a clinically well tolerated NMDA receptor antagonist\u2010a review of preclinical data. Neuropharmacology. In press.","DOI":"10.1016\/S0028-3908(99)00019-2"},{"issue":"4","key":"e_1_2_6_49_2","first-page":"S303","article-title":"Clinical improvement in a placebo\u2010controlled trial with memantine in care\u2010dependent patients with severe dementia [abstract]","volume":"19","author":"Winblad B.","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"e_1_2_6_50_2","unstructured":"Winblad B. & N. Poritis. 1999. Memantine in severe dementia. J. Geriatr. Psychiatry Neurol. In press."},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1159\/000106718"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1993.00540080076020"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.26.7.1293"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.28.3.652"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.27.4.761"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410190306"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2000.tb06407.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2000.tb06407.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:56:51Z","timestamp":1695625011000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2000.tb06407.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1111\/j.1749-6632.2000.tb06407.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06407.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}